The table below shows BioRestorative Therapies, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$23.17K
$11.80K
$303.30K
$25.00K
$233.60K
$89.10K
Cost of revenue
$7.38K
$10.57K
$8.73K
$2.91K
$18.24K
$6.49K
Gross profit
$15.79K
$1.23K
$294.57K
$22.09K
$215.36K
$82.61K
R&D
$1.93M
$2.59M
$2.23M
$2.65M
$1.45M
$1.45M
BRTX annual revenue (10-K history)
BioRestorative Therapies, Inc. reported annual revenue of $359.70K for fiscal year 2025. That is down 10.3% from $401.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $36.35K (FY 2016) to $359.70K. Figures come from the company's audited annual reports as filed with the SEC.